A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy in Japanese Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-050)
PHASE3CompletedINTERVENTIONAL
Enrollment
68
Participants
Timeline
Start Date
May 31, 2013
Primary Completion Date
May 31, 2014
Study Completion Date
May 31, 2014
Conditions
Heterozygous Familial Hypercholesterolemia (HeFH)
Interventions
DRUG
Anacetrapib
DRUG
Placebo for anacetrapib
All Listed Sponsors
lead
Merck Sharp & Dohme LLC
INDUSTRY
NCT01824238 - A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy in Japanese Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-050) | Biotech Hunter | Biotech Hunter